8-K//Current report
Amylyx Pharmaceuticals, Inc. 8-K
Accession 0001193125-25-268043
$AMLXCIK 0001658551operating
Filed
Nov 5, 7:00 PM ET
Accepted
Nov 6, 7:03 AM ET
Size
384.4 KB
Accession
0001193125-25-268043
Documents
- 8-Kamlx-20251106.htmPrimary
8-K
- EX-99.1amlx-ex99_1.htm
EX-99.1
- GRAPHICimg212534189_0.jpg
GRAPHIC
- EX-101.SCHamlx-20251106.xsd
XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT
- XMLR1.htm
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001193125-25-268043-xbrl.zip
IDEA: XBRL DOCUMENT
- XMLamlx-20251106_htm.xml
IDEA: XBRL DOCUMENT
Issuer
Amylyx Pharmaceuticals, Inc.
CIK 0001658551
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001658551
Filing Metadata
- Form type
- 8-K
- Filed
- Nov 5, 7:00 PM ET
- Accepted
- Nov 6, 7:03 AM ET
- Size
- 384.4 KB